Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats
about
Differentiation of insulin-producing cells from human neural progenitor cellsGlucagon-like peptide analogues for type 2 diabetes mellitusGlucagon-like peptide analogues for type 2 diabetes mellitusGlucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferationRETRACTED: Betatrophin: a hormone that controls pancreatic β cell proliferationMarked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumorsDiabetes outfoxed by GLP-1?Beneficial endocrine but adverse exocrine effects of sitagliptin in the human islet amyloid polypeptide transgenic rat model of type 2 diabetes: interactions with metforminMechanisms of action of glucagon-like peptide 1 in the pancreasDirected differentiation of rhesus monkey ES cells into pancreatic cell phenotypesThe L-Cell in Nutritional Sensing and the Regulation of AppetiteStructure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptorsReviewing the Effects of L-Leucine Supplementation in the Regulation of Food Intake, Energy Balance, and Glucose HomeostasisTreatment of autoimmune diabetes by inhibiting the initial eventFrom Beta cell replacement to beta cell regeneration: implications for antidiabetic therapySomething old, something new and something very old: drugs for treating type 2 diabetesIncretins and the intensivist: what are they and what does an intensivist need to know about them?Concise review: pancreas regeneration: recent advances and perspectivesUse of glucagon-like peptide-1 agonists to improve islet graft performanceDevelopment, growth and maintenance of β-cell mass: models are also part of the storyA Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic MiceThe effects of exendin-4 treatment on graft failure: an animal study using a novel re-vascularized minimal human islet transplant modelCrystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 ReceptorICA512 signaling enhances pancreatic beta-cell proliferation by regulating cyclins D through STATsStructure-function of the glucagon receptor family of G protein-coupled receptors: the glucagon, GIP, GLP-1, and GLP-2 receptorsCurrent status of regeneration of pancreatic β-cellsRgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetesInsulin-producing cells generated from dedifferentiated human pancreatic beta cells expanded in vitroLack of Wdr13 gene in mice leads to enhanced pancreatic beta cell proliferation, hyperinsulinemia and mild obesityLiraglutide improves pancreatic Beta cell mass and function in alloxan-induced diabetic miceAdenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replicationGlucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signalingResponse to comments on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:25The role of TNF-α in mice with type 1- and 2- diabetesEmerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetesTreatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trialPancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and massA nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice.The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury.Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
P2860
Q21092394-D5199C81-C613-4446-90E6-C46CB5937BD7Q24235918-4BA2C3D8-94AE-42D7-9CD3-4920BF6DFC8CQ24243685-E6B27F71-96CE-43CD-BCED-5DA2D84B2585Q24307581-90ACF217-B143-4BE7-9F3A-C3CB6522AC20Q24339335-0FCCD539-E7DE-45F5-8B85-386013DE4B28Q24598747-6E1C3402-34C3-4409-83AC-DB37320471E3Q24603443-8007A305-612C-4D3A-8E90-B2167C057CFDQ24642412-086CE028-99A3-47EF-945B-1A527F60DA18Q24683764-F46B6F47-634C-46A2-8D09-DD735D240CECQ24802550-797BC62D-D58A-4A2E-8040-8C68FE2FE2FBQ26799942-603D94F0-DB49-4913-A46E-DC7A5F027A27Q26851381-E9513818-F89C-4C6E-B957-AD22C9DE949FQ26852743-F0039382-5C12-4691-A941-65FACBE006CDQ26863647-F650D3C8-B318-4B3F-85C2-0C9EC4FD8464Q26864024-34400128-66D8-4888-A90E-E5DE89B87600Q26865663-E54B134B-09E4-4D6B-9493-5F3BFE3087EFQ26995464-B5659EC7-A310-458B-BB9B-0E90547C37BFQ27013646-DE9E0996-21F8-4391-8BF5-6746E2F3BFE3Q27013927-92CB21A7-69EB-4904-BCE3-5532CAF50F83Q27020942-189C3B78-043C-4B5C-B079-76AEA5E27811Q27301757-DB62DF6B-3B4D-4D37-AE4F-D31FCA416440Q27311069-576AEA19-4AFB-48AA-9FBF-10ADC74B2884Q27657999-9947FE7B-A5C0-487C-8742-84743B4C09DBQ28115798-4FA7078D-01FD-4F74-8A1A-0852B20DDBD7Q28203273-2926A67B-7D9B-4BE5-B021-0224DACF5E0DQ28240432-391C8785-ADA4-4023-A3CB-9F8F2DF8AF6CQ28287448-18522A67-E5F9-45CB-9886-9FE4C2A8ADBDQ28477311-6FABE947-6E0F-4EA1-853C-7A47C8C734A9Q28484169-AAD801E7-75C4-4BCB-AC20-24D54334DE5DQ28546996-E336D5A8-A8B2-43B1-AFF9-9BEB2A7045CDQ28568760-F5CDB066-CC1D-42C7-8E97-2030912F19A4Q28581928-4708DD08-D20C-4919-A222-EEC52EA30263Q28679307-7504C55E-6785-4E0B-8935-FBE98F3A8A8EQ28730016-46B29B24-0D08-47BF-A6F3-B5AA33BBD740Q28762629-6D91896E-D3EF-4D35-8C9F-9307E31B1CE1Q30489980-989AAF94-3007-4C7B-AC4B-A72BD058EF55Q30490044-51CD54E9-32C2-4A73-86D9-CA15D507D675Q33268721-76FB161D-FF2D-4760-9FBF-0668F0D662C5Q33428592-2E36A831-581B-4B9A-A109-C96F38FEDA2EQ33521451-2F921A82-C8E0-45E3-9061-249BD7510C68
P2860
Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats
description
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1999
@ast
im Dezember 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/12/01)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/12/01)
@nl
наукова стаття, опублікована в грудні 1999
@uk
مقالة علمية (نشرت في ديسمبر 1999)
@ar
name
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@ast
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@en
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@nl
type
label
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@ast
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@en
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@nl
prefLabel
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@ast
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@en
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@nl
P2093
P3181
P1433
P1476
Exendin-4 stimulates both beta ...... ose tolerance in diabetic rats
@en
P2093
D. A. Stoffers
J. F. Habener
S. Bonner-Weir
P304
P3181
P356
10.2337/DIABETES.48.12.2270
P407
P577
1999-12-01T00:00:00Z